Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Please help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
 
NOTE: November 18,2017:
HAVE NOT HAD A GIFT OF SUPPORT SINCE SEPTEMBER 26, 2017.
I CANNOT AFFORD THIS ENTIRE PROJECT ALONE.
 
The site ended up going down for two days because I was late with last months' hosting fees. I can't come up with enough money again this month for the hosting fees due on November 26. Without financial support, the site and all content will likely go down again.
 
PLEASE, PLEASE HELP...
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Letter to CitiCorp Matthew Dodds RE: $JNJ 3rd quarter 2013 Conference Call
Since Orsinger danced around issues causing delays in completion of Synthes acquisition and basically said nothing, I figured I'd give him a real answer.

Keywords: johnson & johnson, JNJ, j&j, matthew dodds, citicorp, financial analyst, orsinger
Date Created/Edited: October 17, 2013
 
Matthew Dodds
Citigroup, Inc.
Director Medical Supplies & Technology
399 Park Avenue
New York, New York 10043
United States
 
RE: Johnson & Johnson 3rd Quarter Teleconference: 14 October 2013
 
Dear Matthew Dodds,
 
My name is Emily Patterson. I am the creator of and researcher for a web site called Johnson and Toxin. After reading the transcript of the 3rd quarter 2013 teleconference with Johnson & Johnson Vice President of Finance, Dominic Caruso and Johnson & Johnson Worldwide Chairman of DePuy Synthes companies, Michel Orsinger, I felt your questions required a little more realistic clarification.
 
You have a very valid concern regarding why the Synthes acquisition, which started in the last quarter of 2012, is costing additional money and continues to drag on almost a year later. I agree that it would be very nice if Johnson & Johnson were able to give a rock-solid time frame for completion of this long, drawn-out process - or at least clarify what is taking so long and costing so much in addition to the original acquisition price.
 
As you may be aware, not long before the Johnson & Johnson acquisition of Synthes, a major corruption scandal regarding bone cement, a Synthes Norian product, had recently been partially resolved. Michel Orsinger, as president of Norian Corporation, signed the Synthes Norian Settlement Agreement on 20 September, 2010. Four of the indicted managers served prison sentences and $100,000 fines for the scandal.
 
Lawsuits have begun for the three known dead victims of illegally testing a new procedure on humans when animal studies had already proven the increased risk of death from using the product injected into the spine. I'm sure Mr. Orsinger, as Worldwide Chairman of DePuy Synthes is very busy with Norian, now a subsidy of Kensey Nash, trying to figure out how to handle these lawsuits.
 
Mr. Orsinger, as Worldwide Chairman of DePuy Synthes, is likely also very busy wrapping up misbranding and customer complaint reporting issues at Synthes. These issues were brought to Mr. Orsigner's attention with a Warning Letter by the United States Food and Drug Administration which states numerous violations in misbranding of currently available Johnson & Johnson DePuy Synthes products. In addition, the FDA Warning Letter clearly shows inadequate handling of customer complaints with regard to registering complaints with the FDA for review in violation of FDA regulations.
 
It is my hope that these issues will be brought under control as soon as possible. However, litigation, settlements, rebranding and creating an FDA compliant customer complaint process takes an unknown amount time and money to resolve so any forward-thinking completion date or final total cost is unavailable at this time, which is likely why Mr. Orsinger gave you a complete and total non-answer during the 2013 3rd quarter conference call.
 
I hope this provided a more detailed explanation for your concerns,
Emily Patterson
 
cc:
Alex Gorsky
Dominic Caruso
Michel Orsinger
Barack Obama

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 

 


 
Resources:
1. TRANSCRIPT (2013, October 15). Johnson & Johnson's Management Discusses Q3 2013 Results - Earnings Call Transcript. Seeking Alpha. Retrieved from http://seekingalpha.com/article/1746172-johnson-and-johnsons-management-discusses-q3-2013-results-earnings-call-transcript?page=11&p=qanda&l=last
 
2. Roslyn Rudolph (2010, September 20). Synthes Norian Settlement Agreement. Scribd. Retrieved from http://www.scribd.com/doc/56855255/Synthes-Norian-Settlement-Agreement
 
3. David Sell (2011, December 14). Fourth ex-Synthes executive sentenced in illegal use of bone cements. Philly.com. Retrieved from http://www.philly.com/philly/business/20111214_Fourth_ex-Synthes_executive_sentenced_in_illegal_use_of_bone_cements.html
 
4. Kirk Sooter (2012, March 7). Warning Letter by the United States Food and Drug Administration. United States Food and Drug Administration. Retrieved from www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm294688.htm
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries